ATE139119T1 - Modulierung der reaktion von adenylatcyclase - Google Patents

Modulierung der reaktion von adenylatcyclase

Info

Publication number: ATE139119T1
Authority: AT; Austria
Prior art keywords: silicic acid; modulation; adenylatcyclase; reaction; bone strength
Prior art date: 1988-12-27

Application number

AT90901474T

Other languages

English (en)

Inventor

Karl E Wiegand

Robert K Rude

Original Assignee

Ethyl Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1988-12-27

Filing date

1989-12-22

Publication date

1996-06-15

1989-12-22 Application filed by Ethyl Corp filed Critical Ethyl Corp

1996-06-15 Application granted granted Critical

1996-06-15 Publication of ATE139119T1 publication Critical patent/ATE139119T1/de

Links

RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 abstract 3
235000012239 silicon dioxide Nutrition 0.000 abstract 3
230000037118 bone strength Effects 0.000 abstract 2
230000000694 effects Effects 0.000 abstract 2
208000020084 Bone disease Diseases 0.000 abstract 1
OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 abstract 1
241000251539 Vertebrata <Metazoa> Species 0.000 abstract 1
UDMBCSSLTHHNCD-KQYNXXCUSA-N adenosine 5'-monophosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O UDMBCSSLTHHNCD-KQYNXXCUSA-N 0.000 abstract 1
229910052791 calcium Inorganic materials 0.000 abstract 1
239000011575 calcium Substances 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
229940088597 hormone Drugs 0.000 abstract 1
239000005556 hormone Substances 0.000 abstract 1
230000000944 neurotransmitter response Effects 0.000 abstract 1
210000001519 tissue Anatomy 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/88—Lyases (4.)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Genetics & Genomics (AREA)
Wood Science & Technology (AREA)
Zoology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Biochemistry (AREA)
Molecular Biology (AREA)
Biomedical Technology (AREA)
Biotechnology (AREA)
Microbiology (AREA)
General Engineering & Computer Science (AREA)
Diabetes (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Epidemiology (AREA)
Inorganic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Emergency Medicine (AREA)
Endocrinology (AREA)
Hematology (AREA)
Obesity (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Enzymes And Modification Thereof (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Stabilization Of Oscillater, Synchronisation, Frequency Synthesizers (AREA)
Steroid Compounds (AREA)

AT90901474T 1988-12-27 1989-12-22 Modulierung der reaktion von adenylatcyclase ATE139119T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US07/290,307 US4954448A (en)	1988-12-27	1988-12-27	Modulation of adenylate cyclase response

Publications (1)

Publication Number	Publication Date
ATE139119T1 true ATE139119T1 (de)	1996-06-15

Family

ID=23115404

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT90901474T ATE139119T1 (de)	1988-12-27	1989-12-22	Modulierung der reaktion von adenylatcyclase

Country Status (10)

Country	Link
US (1)	US4954448A (de)
EP (1)	EP0451203B1 (de)
JP (1)	JP2960962B2 (de)
KR (1)	KR0133729B1 (de)
AT (1)	ATE139119T1 (de)
AU (1)	AU630143B2 (de)
CA (1)	CA1336066C (de)
DE (1)	DE68926682T2 (de)
ES (1)	ES2090121T3 (de)
WO (1)	WO1990007574A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5183061A (en) *	1988-07-22	1993-02-02	Ethyl Corporation	Silicon compounds in bone treatment
US5122603A (en) *	1989-03-08	1992-06-16	The University Of Virginia Alumni Patents Foundation	Purified insulin mediators and purification process for same
EP0799259B1 (de) *	1994-12-21	1999-07-07	Zeneca Limited	Verfahren zum pfropfen
GB0504657D0 (en) *	2005-03-05	2005-04-13	Psimedica Ltd	Compositions and methods of treatment
EP2070541A4 (de) *	2006-09-21	2011-04-13	Toshiki Oguro	Mittel zur förderung der regeneration von hartem gewebe
US11490601B2 (en) *	2020-12-23	2022-11-08	X Development Llc	Self-calibrating ultrasonic removal of ectoparasites from fish

1988
- 1988-12-27 US US07/290,307 patent/US4954448A/en not_active Expired - Lifetime
1989
- 1989-09-29 CA CA000615052A patent/CA1336066C/en not_active Expired - Lifetime
- 1989-12-22 WO PCT/US1989/005799 patent/WO1990007574A1/en not_active Ceased
- 1989-12-22 AU AU48373/90A patent/AU630143B2/en not_active Ceased
- 1989-12-22 AT AT90901474T patent/ATE139119T1/de not_active IP Right Cessation
- 1989-12-22 JP JP2501915A patent/JP2960962B2/ja not_active Expired - Fee Related
- 1989-12-22 DE DE68926682T patent/DE68926682T2/de not_active Expired - Fee Related
- 1989-12-22 ES ES90901474T patent/ES2090121T3/es not_active Expired - Lifetime
- 1989-12-22 KR KR1019900701888A patent/KR0133729B1/ko not_active Expired - Fee Related
- 1989-12-22 EP EP90901474A patent/EP0451203B1/de not_active Expired - Lifetime

Also Published As

Publication number	Publication date
WO1990007574A1 (en)	1990-07-12
US4954448A (en)	1990-09-04
ES2090121T3 (es)	1996-10-16
EP0451203A1 (de)	1991-10-16
KR0133729B1 (ko)	1998-04-21
JPH04504653A (ja)	1992-08-20
JP2960962B2 (ja)	1999-10-12
AU630143B2 (en)	1992-10-22
EP0451203A4 (en)	1991-12-11
DE68926682D1 (de)	1996-07-18
AU4837390A (en)	1990-08-01
KR910700337A (ko)	1991-03-14
CA1336066C (en)	1995-06-27
DE68926682T2 (de)	1996-11-28
EP0451203B1 (de)	1996-06-12

Similar Documents

Publication	Publication Date	Title
NO921454L (no)	1992-06-10	Fremgangsmaater og blandinger for heling av ben
IT8419266A0 (it)	1984-01-20	Tessuti del corpo umano e dispositivo per generare calore in procedimento di generazione dicalore, particolarmente per la cura di tumori.
ATE97316T1 (de)	1993-12-15	Kosmetisches mittel und zusammensetzung zur behandlung der haut.
ZA907056B (en)	1991-12-24	Laser light irradiation apparatus
ATE127691T1 (de)	1995-09-15	Verwendung von vitamin-d-analoga zur behandlung von akne.
ATE112684T1 (de)	1994-10-15	Verwendung von igf-ii zur behandlung von knochenkrankheiten.
ATE249819T1 (de)	2003-10-15	Präparate zur äusserlichen anwendung zur behandlung von dermatosen
DE69228997D1 (de)	1999-05-27	Menschliche il-3-varianten
MX9805705A (es)	1998-10-31	Compuestos biaromaticos, composiciones farmaceuticas y cosmeticas que los contienen y utilizaciones.
ES2188582T3 (es)	2003-07-01	El uso de ranitidina-citrato de bismuto en combinacion con claritromicina o claritromicina y tetraciclina en la fabricacion de un medicamento para tratar trastornos gastrointestinales.
ES2075893T3 (es)	1995-10-16	Activacion in vivo especifica de sede de farmacos terapeuticos.
ATE139119T1 (de)	1996-06-15	Modulierung der reaktion von adenylatcyclase
JPS57122085A (en)	1982-07-29	Circulatory disease extirpenter and use
DK1063981T3 (da)	2002-10-14	Anvendelse af selegilin eller desmethylselegilin til behandling af sår, brandsår og dermatologiske skader
MX9806188A (es)	1998-10-31	Derivados de acidos benzofurano-acrilicos y su utilizacion como moduladores de los receptores rxrs o rars.
ATE181668T1 (de)	1999-07-15	Verwendung von 5-ht4 rezeptorantagonisten zur behandlung von vorhof-fibrillation und zur vorbeugung von schlaganfall
ZA878249B (en)	1989-07-26	Method and therapeutic compositions for the treatment of bleeding disorders
ATE64300T1 (de)	1991-06-15	Wirkstoffe zur anwendung bei der behandlung von tumoren.
ES2051687T3 (es)	1994-07-01	Procedimiento de preparar un gel basico coloidal que contiene pirimicina.
ES2110057T3 (es)	1998-02-01	Composicion medicinal que contiene tcf-ii.
ES2085199B1 (es)	1996-12-01	Un procedimiento para la preparacion de una formulacion depot.
KR930702016A (ko)	1993-09-08	골다공증 치료제
ES2042724T3 (es)	1993-12-16	Una composicion terapeutica o profilactica.
ZA988569B (en)	1999-03-30	Veterinary medicine containing native or modified equine choriogonadotrophin to induce ovulation in mares and stimulate the production of testosterone in stallions
DE3485282D1 (de)	1992-01-02	Zusammensetzung zur behandlung von boesartigen tumoren insbesondere bei tieren.

Legal Events

Date	Code	Title	Description
1996-12-15	UEP	Publication of translation of european patent specification
2005-09-15	REN	Ceased due to non-payment of the annual fee